• Non ci sono risultati.

Imaging of Renal Perfusion 39

N/A
N/A
Protected

Academic year: 2021

Condividi "Imaging of Renal Perfusion 39"

Copied!
8
0
0

Testo completo

(1)

H. J. Michaely, MD

Department of Clinical Radiology, University Hospitals – Gross hadern, Ludwig Maximilian University of Munich, Marchioni nistr. 15, 81377 Munich, Germany

N. Oesingmann, PhD

Siemens Medical Solutions USA, Inc., MR R&D Collaboration, NYU CBI, 660 First Avenue, New York, NY 10016, USA

C O N T E N T S

39.1 Introduction 441

39.2 Arterial Spin-Labeling Perfusion

Measurements 442

39.3 First-Pass Perfusion 442

References 447

Imaging of Renal Perfusion 39

Henrik J. Michaely and Niels Oesingmann

39.1

Introduction

In the past years, the focus of MR imaging of the kidneys has changed from pure visualization of renal (vessel) morphology and the grading of renal- artery stenosis (RAS) by MR angiography (MRA) (Schoenberg et al. 2003; Shetty et al. 2000; Tan et al. 2002; Prince 1998) to more comprehensive approaches. These include MR fl ow measurements to evaluate the hemodynamic signifi cance of a RAS (de Haan et al. 2000; de Haan et al. 2003; Schoen- berg et al. 2000) and more recently also renal per- fusion measurements (Michaely et al. 2006a; Lee et al. 2001; Gandy et al. 2003; Montet et al. 2003; Lee et al. 2003; Karger et al. 2000; Michaely et al. 2004;

Michaely et al. 2005a). While the MRA and MR fl ow measurements can characterize the renal macrovas- culature, perfusion is intended to display the renal microvasculature. Hence, perfusion measurements

aim at demonstrating the capillary blood fl ow in the renal parenchyma, and especially in the highly vascu- larized renal cortex. The literature presents multiple concepts for renal perfusion imaging (Michaely et al. 2006a; Lee et al. 2001; Gandy et al. 2003; Lee et al. 2003; Karger et al. 2000; Michaely et al. 2004;

Aumann et al. 2003; Berr et al. 1999; Bjornerud et al.

2002; Ichikawa et al. 1997; Laissy et al. 1994; Prasad et al. 1999; Roberts et al. 1995; Schoenberg et al.

2003; Trillaud et al. 1993; Vallee et al. 2000; Wil- liams et al. 1994; Michaely et al. 2005b). In general, three different methods for MR perfusion imaging of the kidney have been described for renal artery steno- sis, namely qualitative assessment of renal perfusion with arterial spin-labeling (ASL) techniques without contrast agents, semi-quantitative perfusion meas- urements with extracellular gadolinium chelates, and quantitative assessment of renal perfusion with intra- vascular contrast agents with absolute parameters of regional renal perfusion (Michaely et al. 2006a;

Aumann et al. 2003; Prasad et al. 1999). Even though they are all subsumed under renal perfusion, they use different techniques and thus have different aims.

Contrast-enhanced (CE) fi rst-pass perfusion studies mainly aim at assessing the impact of renal artery stenosis or renal parenchymal disease on the paren- chymal perfusion or aim at assessing the patency of a renal artery stent (Gandy et al. 2003; Michaely et al. 2005a; Vallee et al. 2000).

An approach completely different from the CE techniques is arterial spin labeling where blood is used as endogenous contrast agent (Karger et al.

2000; Michaely et al. 2004; De Bazelaire et al.

2005; Gunther et al. 2001; Martirosian et al. 2004).

Depending on the specifi c technique used, ASL tech- niques may be able to yield only perfusion-weighted images (Michaely et al. 2004) or to exactly calculate the renal perfusion (Martirosian et al. 2004).

The clinical relevance of perfusion measurements

is underlined by publications showing that reduced

renal perfusion is associated with increased rates of

morbidity and mortality in different settings (Fan et

(2)

al. 1990; Hillege et al. 2000). Interestingly, decreased fi rst-pass perfusion parameters were also found in hypertensive rats without renal artery stenosis and were found to improve under therapy (Lenhard et al. 2003). This may indicate that fi rst-pass perfusion could also be applied to the detection and monitoring of chronic renal failure in the future.

39.2

Arterial Spin-Labeling Perfusion Measurements

ASL techniques are attractive in that they are non- invasive and do not require the administration of contrast agents (Michaely et al. 2004). In addition, many ASL sequences can be acquired within a single breath-hold. Different techniques have been pro- posed so far in the literature, however mainly animal studies or volunteer studies have been performed (Karger et al. 2000; Roberts et al. 1995; Williams et al. 1994; Wang et al. 1998). The basic idea of ASL is to acquire two images that are post-processed to obtain a perfusion-weighted image without the use of contrast agents. In one image, in-fl owing blood is labeled with an RF pulse, while a control image without blood labeling is acquired for subtraction to suppress signal from stationary tissue.

A commonly used technique is the so-called fl ow- sensitive alternating inversion-recovery method (FAIR) (Michaely et al. 2004). In this technique, fi rst a non-selective global inversion is applied for the labeling image, whereas the control image is acquired with selective inversion only. The stationary tissue is inverted in both images and thus disappears with the subtraction. This completely symmetric inversion scheme has the advantage of reducing magnetization transfer effects. However, no image information is sampled during the delay time, so that FAIR measure- ments are relatively ineffi cient and time-consuming.

To overcome this problem a Look-Locker acquisi- tion has been proposed (Gunther et al. 2001) that samples a series of images after each labeling pulse instead of just one image. This technique also over- comes the limitation of many ASL sequences to gener- ate only a single perfusion-weighted slice without the temporal perfusion information and thereby possibly offers quantifi cation of perfusion. Other approaches for ASL perfusion include STAR and EPISTAR tech- niques (Prasad et al. 1997) with an EPI readout

module being implemented into the latter. However, one disadvantage of STAR is the induction of magneti- zation-transfer contrast (MTC) caused by the specifi c labeling technique used. Recently, a steady-state free precession TrueFISP-readout for ASL sequences has been presented to increase the signal-to-noise ratio (SNR) and to decrease the susceptibility for artefacts (Martirosian et al. 2004), which allowed absolute quantifi cation of the perfusion.

One major disadvantage of using arterial spin labeling techniques for renal perfusion imaging is the poor signal-to-noise ratio of this approach at 1.5 T. This makes the calculation of semi-quantita- tive or quantitative parameters of renal perfusion diffi cult and unreliable, although some authors have presented absolute values of renal perfusion with modifi ed ASL techniques and acceptable reproduc- ibility (Karger et al. 2000). Newer approaches used a FAIR-TrueFISP readout (Martirosian et al. 2004) to yield a higher SNR than with the conventionally used FAIR-HASTE (Michaely et al. 2004) or FAIR-EPI (Gunther et al. 2001) readouts. Also, the transition to higher fi eld strength will surely be benefi cial for ASL measurements, as with the longer T1 relaxation times at higher fi eld strength the magnetic labeling will decay more slowly (Michaely et al. 2004; Thul- born 1999). Another major drawback associated with the low inherent SNR of ASL measurements is the sensitivity to susceptibility artefacts. While the application of parallel imaging would be disadvanta- geous in terms of SNR, it will be helpful in avoiding or reducing susceptibility artefacts, particularly with EPI readouts. Since suffi cient SNR for the application of parallel imaging is only available at higher fi eld strengths, ASL will surely profi t from the increasing number of high-fi eld scanners. However, no reports on the combination of parallel imaging and ASL exist so far for abdominal applications. In brain perfusion, the feasibility of ASL with parallel imaging has been proven (Wang et al. 2005).

39.3

First-Pass Perfusion

In contrast to the ASL techniques, CE MR perfusion

techniques do not suffer from SNR limitations. A bolus

of paramagnetic contrast agent such as Gd-DTPA or

Gd-BOPTA is administered at a high fl ow rate of 3 to

4 ml/s to obtain a well-defi ned bolus. Different reports

(3)

have been published about the ideal amount of con- trast agent raging from a 2 ml fl at dose (Lee et al. 2001) to 0.1 mmol/kg body weight (Michaely et al. 2006a).

The fi rst pass of the contrast-agent bolus is imaged with a high temporal resolution to fi nally obtain a signal-intensity-versus-time curve. Depending on the approach used, a semi-quantitative or quantitative measurement of the perfusion can be achieved with standard, extracellular contrast agents. The applied sequence techniques are characterized by a high tem- poral resolution, which is required to sample enough data points of the contrast agent bolus passing through the kidneys. In the literature VIBE (Gandy et al. 2003) sequences, TurboFLASH sequences (Michaely et al.

2006a; Trillaud et al. 1993) and fast gradient-echo (GRE) sequences without magnetization preparation (Vallee et al. 2000) are used to visualize the signal increase with standard contrast agents. With the application of intravascular contrast agents, such as investigational drugs including NC 100150 (Nycomed, Oslo, Norway), T2*-based techniques can be applied (Aumann et al. 2003; Schoenberg et al. 2003;

Trillaud et al. 1993). Recently approved strongly pro- tein-binding gadolinium chelates with semi-intravas- cular properties allow the absolute quantifi cation of renal perfusion with T1-weighted saturation-recovery GRE techniques (Prasad et al. 1999).

Perfusion data require intensive postprocessing to determine either semiquantitative parameters such as the mean transit time and the maximum upslope of the signal-intensity-versus-time curve (Fig. 39.1) (Michaely et al. 2006a; Gandy et al. 2003) or abso- lute parameters of renal perfusion such as blood fl ow per minute and 100 g of renal tissue. While semi- quantitative approaches are more robust, but some- what limited in their information, absolute quantifi - cation requires correction of the data by the arterial input function. For patients with renal artery stenosis (Fig. 39.2) the semiquantitavtive approach revealed signifi cant differences in the mean transit time and the maximal upslope of the signal-intensity-versus- time curve between patients with high-grade renal artery stenosis (>75% diameter) and healthy patients (Michaely et al. 2006a). In a study by Vallee et al.

(2000), a signifi cantly decreased absolute renal blood fl ow in patients with renal artery stenosis or renal fail- ure of 0.51 ml/min/g compared to 2.54 ml/min/g in healthy kidneys was found. Apart from this approach in which the signal intensity was converted into the concentration of the contrast agent, other approaches with deconvolution algorithms for quantifi cation of renal perfusion (Aumann et al. 2003; Dujardin et al.

2004; Johansson et al. 2003) have been published as well. However, none of these techniques have found widespread acceptance as major technical hurdles for fast and reliable deconvolution techniques have to be overcome in the future.

Initial results using parallel imaging for semi- quantitative assessment of kidneys were presented by Michaely et al. Hereby, the number of slices, which can be measured during the fi rst pass of the contrast agent bolus, could be increased from four to six. The applied TurboFLASH sequence used the GRAPPA algorithm, which led to some increased background noise. However, in an intraindividual comparison study of TurboFLASH without parallel imaging versus TurboFLASH with parallel imaging, the semiquantitative parameters were found to be statistically not different. While at 1.5 T the noise is signifi cantly increased with parallel imaging, imag- ing at 3.0 T offers suffi cient SNR for fast imaging with the application of parallel-imaging techniques.

Initial results of perfusion imaging at 3.0 T found superior image quality with a 60% increase in SNR even with the application of parallel-imaging tech- niques. The semiquantitative perfusion parameters were not statistically signifi cant to 1.5 T again (sub- mitted data). An example for 3.0-T perfusion can be found in Fig. 39.3.

A different methodological approach for the depic- tion of the renal perfusion is time-resolved MRA tech-

Fig. 39.1. This scheme demonstrates how the perfusion pa-

rameters maximal signal intensity (1), maximal upslope (2),

mean transit time (3) and the time-to-peak signal intensity

are derived based on a Gamma-variate fi t from the fi rst pass

part of the signal-intensity-versus-time curve. Reprinted with

permission from (Michaely et al. 2006b)

(4)

Fig. 39.2. a Thin MIP of an MRA of a patient without renal artery stenosis demonstrating a healthy renal artery. b The signal- intensity-versus-time curve of this patient reveals a regular curve with a steep upslope and a marked peak. c Thin MIP of a patient with high-grade renal artery stenosis (arrow) at the ostium of the renal artery. d The signal-intensity versus time curve of this patient demonstrates a markedly slower upslope of the perfusion curve with a less pointed peak (compare to b). Reprinted with permission from (Michaely et al. 2006b)

Fig. 39.3. a Exemplary images of a TurboFLASH perfusion measurement in a 29-year-old healthy volunteer. This sequence was acquired without parallel imaging, which allowed acquiring four slices per second. In this early arterial phase, there is marked enhancement in the aorta and the renal cortices. b Exemplary images of a TurboFLASH perfusion measurement in the same 29-year-old healthy volunteer as shown in a. This sequence was acquired with parallel imaging, which allowed acquiring six slices per second. In this early arterial phase, there is equal enhancement in the aorta and the renal cortices as compared to the images without parallel imaging.

Also, the visual assessment does not reveal a lower SNR of the TurboFLASH sequence with parallel imaging. c Comparison of the signal-intensity-versus-time curves of the two TurboFLASH sequences of the above volunteer. The curves reveal that using parallel a

a c

b d

컄컄

(5)

imaging (PI) the maximal signal intensity is lowered compared to the non-parallel-imaging sequence. d This box plot compares the mean transit time and the time to peak measurements of 15 healthy volunteers who underwent renal TurboFLASH perfusion meas- urements with and without parallel imaging (PI). There is no signifi cant difference between the two different techniques to be seen. e Intra-individual comparison of TurboFLASH perfusion measurements at 1.5 T (upper row) and 3.0 T (lower row). In this volunteer, no parallel imaging was used at 1.5 T; GRAPPA with an acceleration factor of R=2 was used at 3.0 T to increase the number of simultane- ously acquired slices. This example demonstrates the signifi cantly increased SNR at 3.0 T. While the fi rst pass can be well visualized at both fi eld strengths, in later phases of the perfusion measurements the demarcation of the kidneys is much better at 3.0 T

c d

b

e

(6)

niques with high temporal resolution (<2 s/3D frame).

The time-resolved echo-shared angiographic tech- nique (TREAT) (Fink et al. 2005),which is based on the TRICKS (Korosec et al. 1996) technique, com- bines the view-sharing elements with parallel imag- ing to fi nally yield a temporal resolution of 1-2 s per entire 3D frame; cf. Chaps. 7 and 11. This temporal resolution is fast enough to follow the arrival of the contrast agent in the kidney, and hence to obtain accu- rate signal-intensity-versus-time curves from which perfusion parameters can be calculated (Fig. 39.4). In

initial reports where this technique was compared to a conventional TurboFLASH sequence, equal values could be obtained for the assessment of perfusion with both techniques (Michaely et al. 2005a). TREAT offers the additional advantage of exact vessel depic- tion, and the TREAT data can be reformatted in any desired way due to the three-dimensional character of the sequence. However, this property of TREAT also implies that vast amounts of data are acquired, which hinders temporally extended measurements of renal perfusion and fi ltration.

Fig. 39.4. a High-spatial-resolution MRA of a patient with bilateral interme- diate-grade renal artery stenosis at 3.0 T (0.9×0.6×1.4 mm³; GRAPPA; R=2;

22 s acquisition time). b TREAT perfusion study of the same patient at 3.0 T (1.5×1.5×3.0 mm³; GRAPPA; R=3, 1.4 s/3D frame) reveals bilateral symmet- ric perfusion of both renal cortices. These time-resolved angiographic data can also be used to determine the renal perfusion parameters, which were only slightly elevated in this patient

a

b

(7)

References

Aumann S, Schoenberg SO, Just A, Briley-Saebo K, Bjornerud A, Bock M, Brix G (2003) Quantifi cation of renal perfusion using an intravascular contrast agent (part 1): Results in a canine model. Magn Reson Med 49: 276–287

Berr SS, Hagspiel KD, Mai VM, Keilholz-George S, Knight- Scott J, Christopher JM, Spinosa DJ, Angle JF, Matsumoto AH (1999) Perfusion of the kidney using extraslice spin tagging (EST) magnetic resonance imaging. J Magn Reson Imaging 10: 886–891

Bjornerud A, Johansson LO, Ahlstrom HK (2002) Renal T(*)(2) perfusion using an iron oxide nanoparticle contrast agent- -infl uence of T(1) relaxation on the fi rst-pass response.

Magn Reson Med 47: 298–304

De Bazelaire C, Rofsky NM, Duhamel G, Michaelson MD, George D, Alsop DC (2005) Arterial spin labeling blood fl ow magnetic resonance imaging for the characteriza- tion of metastatic renal cell carcinoma (1). Acad Radiol 12:

347–357

de Haan MW, Kouwenhoven M, Kessels AG, van Engelshoven JM (2000) Renal artery blood fl ow: quantifi cation with breath-hold or respiratory triggered phase-contrast MR imaging. Eur Radiol 10: 1133–1137

de Haan MW, van Engelshoven JM, Houben AJ, Kaandorp DW, Kessels AG, Kroon AA, de Leeuw PW (2003) Phase-contrast magnetic resonance fl ow quantifi cation in renal arteries:

comparison with 133Xenon washout measurements. Hy- pertension 41: 114–118

Dujardin M, Sourbron S, van Schuerbeek P, Luypaert R, Os- teaux M (2004) Deconvolution-based MR imaging of renal perfusion and function using dynamic T1 contrast: a fea- sibility study. Proceedings of the International Society for Magnetic Resonance in Medicine

Fann JI, Sarris GE, Mitchell RS, Shumway NE, Stinson EB, Oyer PE, Miller DC (1990) Treatment of patients with aortic dis- section presenting with peripheral vascular complications.

Ann Surg 212: 705–713

Fink C, Ley S, Kroeker R, Requardt M, Kauczor HU, Bock M (2005) Time-resolved contrast-enhanced three-dimension- al magnetic resonance angiography of the chest: combina- tion of parallel imaging With view sharing (TREAT). Invest Radiol 40: 40–48

Gandy SJ, Sudarshan TA, Sheppard DG, Allan LC, McLeay TB, Houston JG (2003) Dynamic MRI contrast enhancement of renal cortex: a functional assessment of renovascular disease in patients with renal artery stenosis. J Magn Reson Imaging 18: 461–466

Gunther M, Bock M, Schad LR (2001) Arterial spin labeling in combination with a look-locker sampling strategy: Infl ow turbo-sampling EPI-FAIR (ITS-FAIR). Magn Reson Med 46: 974–984

Hillege HL, Girbes AR, de Kam PJ, Boomsma F, de Zeeuw D, Charlesworth A, Hampton JR, van Veldhuisen DJ (2000) Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 102:

203–210

Ichikawa T, Haradome H, Hachiya J, Nitatori T, Araki T (1997) Perfusion-weighted MR imaging in the upper abdomen:

preliminary clinical experience in 61 patients. AJR Am J Roentgenol 169: 1061–1066

Johansson LO, Schoenberg SO, Ahlstrom H, Bjornerud A (2003) Comparision of different deconvolution techniques for quantifi cation of renal blood fl ow using an intravascu- lar contrast agent. Proceedings of the International Society for Magnetic Resonance in Medicine

Karger N, Biederer J, Lusse S, Grimm J, Steffens J, Heller M, Gluer C (2000) Quantitation of renal perfusion using arte- rial spin labeling with FAIR-UFLARE. Magn Reson Imag- ing 18: 641–647

Korosec FR, Frayne R, Grist TM, Mistretta CA (1996) Time- resolved contrast-enhanced 3D MR angiography. Magn Reson Med 36: 345–351

Laissy JP, Faraggi M, Lebtahi R, Soyer P, Brillet G, Mery JP, Menu Y, Le Guludec D (1994) Functional evaluation of nor- mal and ischemic kidney by means of gadolinium-DOTA enhanced TurboFLASH MR imaging: a preliminary com- parison with 99Tc-MAG3 dynamic scintigraphy. Magn Re- son Imaging 12: 413–419

Lee VS, Rusinek H, Johnson G, Rofsky NM, Krinsky GA, Wein- reb JC (2001) MR renography with low-dose gadopentetate dimeglumine: feasibility. Radiology 221: 371–379

Lee VS, Rusinek H, Noz ME, Lee P, Raghavan M, Kramer EL (2003) Dynamic three-dimensional MR renography for the measurement of single kidney function: initial experience.

Radiology 227: 289–294

Table 39.1. Imaging parameters for perfusion imaging (exemplary for Siemens Magnetom Avanto 1.5-T scanner)

SR-TurboFLASH

( Michaely et al. 2005b) VIBE

( Lee at al. 2003) TREAT

(Michaly et al. 2005a)

Echo time (ms) 1.04 0.8 1.07

Repetition time (ms) 254 2.2 2.21

Flip angle 12° 9° 20°

Bandwidth (Hz/pixel) 980 720 1,300

Field of view (mm

2

) 400×350 380×380 370×270

Matrix size 192×154 134×256 320×224

Temporal resolution 4 slices/1 s 1 3D slab/3 s 1 3D slab/1.4 s

Voxel (mm³) 2.3×2.1×8 2.8×1.5×4 1.7×1.2×5

Parallel imaging Possible:

Æ 6 slices/1 s

Possible:

Æ improved temp. resolution

GRAPPA, factor 2

(8)

Lenhard SC, Nerurkar SS, Schaeffer TR, Mirabile RC, Boyce RW, Adams DF, Jucker BM, Willette RN (2003) p38 MAPK inhibitors ameliorate target organ damage in hypertension.

Part 2: Improved renal function as assessed by dynamic contrast-enhanced magnetic resonance imaging. J Phar- macol Exp Ther 307: 939-946

Martirosian P, Klose U, Mader I, Schick F (2004) FAIR true- FISP perfusion imaging of the kidneys. Magn Reson Med 51: 353–361

Michaely HJ, Herrmann KA, Kramer H, Dietrich O, Laub G, Reiser MF, Schoenberg SO (2006) High-Resolution Renal MRA: Comparison of Image Quality and Vessel Depic- tion with Different Parallel Imaging Acceleration Factors.

J Magn Reson Imaging (1): 95–100

Michaely HJ, Schoenberg SO, Ittrich C, Dikow R, Bock M, Guen- ther M (2004) Renal disease: value of functional magnetic resonance imaging with fl ow and perfusion measurements.

Invest Radiol 39: 698–705

Michaely HJ, Schoenberg SO, Oesingmann N, Ittrich C, Frie- drich D, Buhlig C, Struwe A, Rieger J, Reininger C, Samtle- ben W, Weiss M, Reiser MF (2006a) Functional assessment of renal artery stenosis using dynamic MR perfusion meas- urements - feasibility study. Radiology 238: 586–596 Montet X, Ivancevic MK, Belenger J, Jorge-Costa M, Pochon S,

Pechere A, Terrier F, Vallee JP (2003) Noninvasive measurement of absolute renal perfusion by contrast medium-enhanced magnetic resonance imaging. Invest Radiol 38: 584–592 Prasad PV, Cannillo J, Chavez DR, Pinchasin ES, Dolan RP,

Walovitch R, Edelman RR (1999) First-pass renal perfusion imaging using MS-325, an albumin-targeted MRI contrast agent. Invest Radiol 34: 566–571

Prasad PV, Kim D, Kaiser AM, Chavez D, Gladstone S, Li W, Buxton RB, Edelman RR (1997) Noninvasive comprehen- sive characterization of renal artery stenosis by combina- tion of STAR angiography and EPISTAR perfusion imag- ing. Magn Reson Med 38: 776–787

Prince MR (1998) Renal MR angiography: a comprehensive approach. J Magn Reson Imaging 8: 511–516

Roberts DA, Detre JA, Bolinger L, Insko EK, Lenkinski RE, Pen- tecost MJ, Leigh JS, Jr. (1995) Renal perfusion in humans:

MR imaging with spin tagging of arterial water. Radiology 196: 281–286

Schoenberg SO, Aumann S, Just A, Bock M, Knopp MV, Jo- hansson LO, Ahlstrom H (2003) Quantifi cation of renal perfusion abnormalities using an intravascular contrast agent (part 2): Results in animals and humans with renal artery stenosis. Magn Reson Med 49: 288–298

Schoenberg SO, Bock M, Kallinowski F, Just A (2000) Correla- tion of hemodynamic impact and morphologic degree of renal artery stenosis in a canine model. J Am Soc Nephrol 11: 2190–2198

Schoenberg SO, Rieger J, Nittka M, Dietrich O, Johannson LO, Reiser MF (2003) Renal MR angiography: current debates and developments in imaging of renal artery stenosis. Sem- in Ultrasound CT MR 24: 255–267

Shetty AN, Bis KG, Kirsch M, Weintraub J, Laub G (2000) Con- trast-enhanced breath-hold three-dimensional magnetic resonance angiography in the evaluation of renal arteries:

optimization of technique and pitfalls. J Magn Reson Imag- ing 12: 912–923

Tan KT, van Beek EJ, Brown PW, van Delden OM, Tijssen J, Ramsay LE (2002) Magnetic resonance angiography for the diagnosis of renal artery stenosis: a meta-analysis. Clin Ra- diol 57: 617–624

Thulborn KR (1999) Clinical rationale for very-high-fi eld (3.0 Tesla) functional magnetic resonance imaging. Top Magn Reson Imaging 10: 37–50

Trillaud H, Grenier N, Degreze P, Louail C, Chambon C, Fran- coni JM (1993) First-pass evaluation of renal perfusion with TurboFLASH MR imaging and superparamagnetic iron oxide particles. J Magn Reson Imaging 3: 83–91 Vallee JP, Lazeyras F, Khan HG, Terrier F (2000) Absolute renal

blood fl ow quantifi cation by dynamic MRI and Gd-DTPA.

Eur Radiol 10: 1245–1252

Wang JJ, Hendrich KS, Jackson EK, Ildstad ST, Williams DS, Ho C (1998) Perfusion quantitation in transplanted rat kidney by MRI with arterial spin labeling. Kidney Int 53:

1783–1791

Wang Z, Wang J, Connick TJ, Wetmore GS, Detre JA (2005) Continuous ASL (CASL) perfusion MRI with an array coil and parallel imaging at 3T. Magn Reson Med 54: 732–737 Williams DS, Zhang W, Koretsky AP, Adler S (1994) Perfusion

imaging of the rat kidney with MR. Radiology 190: 813–

818

Riferimenti

Documenti correlati

2) All of the applications that we see in the sharing economy are so much more dependent on this technology than prior versions of our economy. It takes a little different

ns pulsed Nd:YAG laser operating at third (355 nm) and fourth harmonic (266 nm) was implemented, cumulating pulses to tune the QDs emission as already discussed (section Materials

Reinartz P, Wildberger JE, Schaefer W, et al: Tomographic imaging in the diagnosis of pulmonary embolism: A comparison between V/Q lung scintigraphy in SPECT technique and

Zoom on some simulated cluster images using MCAO (left) and SCAO (right) modes for the model with the IMBH.. The FoV is 0.8 arcsec ×

Beside their contribution to the bitter taste (flavor) of cider and the colour of apple juices due to oxidation products they were also associated with health effects of apple

A Branch-and-Cut algorithm for the exact solution of the MGAP was proposed by Osorio and Laguna [24] who solved to optimality instances with up to 60 jobs, 30 machines and 2

Overcoming the framework of complete controllability in favour of limited and well-defined controllability goals, enables us to numerically investigate the permeability of a number

US follow-up of native scarred kidneys is indicated in patients with chronic renal failure treated with dialysis or renal trans- plantation because they develop the acquired